Patent · US Active

Cannabinoid receptor modulators

US9597340B2 · kind B2 · utility

6Cited by
6References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 24, 2012
Grant dateMar 21, 2017
Priority date
Expiry dateApr 28, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are certain methods useful in the treatment of cancer comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.